BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1385453)

  • 1. Regulation of C-myc and C-Ha-ras oncogene expression by cell shape.
    Farrell RE; Greene JJ
    J Cell Physiol; 1992 Nov; 153(2):429-35. PubMed ID: 1385453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shape-dependent regulation of proliferation in normal and malignant human cells and its alteration by interferon.
    Kulesh DA; Greene JJ
    Cancer Res; 1986 Jun; 46(6):2793-7. PubMed ID: 2421883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive relaxation of Go-arrest controls and altered responsiveness to insulin, EGF and thrombin in CCL39 lung fibroblasts over-expressing myc and ras oncogenes.
    Pichon F; Seuwen K; Pouysségur J; Lagarde AE
    Oncogene; 1988 Oct; 3(4):373-81. PubMed ID: 3078948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
    Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
    Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes.
    Blomhoff HK; Smeland EB; Beiske K; Blomhoff R; Ruud E; Bjøro T; Pfeifer-Ohlsson S; Watt R; Funderud S; Godal T
    J Cell Physiol; 1987 Jun; 131(3):426-33. PubMed ID: 3036888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced expression of c-myc and decreased expression of c-fos protooncogenes in chemically and radiation-transformed C3H/10T1/2 Cl 8 mouse embryo cell lines.
    Shuin T; Billings PC; Lillehaug JR; Patierno SR; Roy-Burman P; Landolph JR
    Cancer Res; 1986 Oct; 46(10):5302-11. PubMed ID: 2875790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-myc gene inactivation during induction of nasopharyngeal carcinoma cells with retinoic acid.
    Jiang N; Zhan F; Cao L; Yao K; Li G
    Chin Med J (Engl); 2000 Sep; 113(9):823-6. PubMed ID: 11776079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model to study c-myc and v-H-ras induced prostate cancer progression in the Copenhagen rat.
    Lehr JE; Pienta KJ; Yamazaki K; Pilat MJ
    Cell Mol Biol (Noisy-le-grand); 1998 Sep; 44(6):949-59. PubMed ID: 9763199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha affects LTR-controlled oncogene expression in transformed mouse fibroblasts at the post-transcriptional level.
    Seliger B; Stark G; Pfizenmaier K
    J Immunol; 1988 Sep; 141(6):2138-44. PubMed ID: 2844896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT.
    Makover D; Cuddy M; Yum S; Bradley K; Alpers J; Sukhatme V; Reed JC
    Oncogene; 1991 Mar; 6(3):455-60. PubMed ID: 2011401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
    Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II.
    Liu P; Terradillos O; Renard CA; Feldmann G; Buendia MA; Bernuau D
    Hepatology; 1997 Apr; 25(4):874-83. PubMed ID: 9096591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation.
    Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F
    Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-myc gene-induced alterations in protein kinase C expression: a possible mechanism facilitating myc-ras gene complementation.
    Barr LF; Mabry M; Nelkin BD; Tyler G; May WS; Baylin SB
    Cancer Res; 1991 Oct; 51(20):5514-9. PubMed ID: 1655253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types.
    Prins J; De Vries EG; Mulder NH
    Anticancer Res; 1993; 13(5A):1373-85. PubMed ID: 8239508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the Bowman-Birk protease inhibitor on the expression of oncogenes in the irradiated rat colon.
    St Clair WH; St Clair DK
    Cancer Res; 1991 Sep; 51(17):4539-43. PubMed ID: 1908349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antisense c-Ha-ras oligodeoxynucleotides inhibit the proliferation of the gastrocarcinoma-DNA-transformed rat 3-3 cells and reduce the p21 expression of the cells.
    Xu Y; Deng GR; Liang YY; Li C
    Sci China B; 1991 Jan; 34(1):35-41. PubMed ID: 2015062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
    Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
    Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of the clusterin gene by Ha-ras and c-myc oncogenes and during apoptosis.
    Klock G; Storch S; Rickert J; Gutacker C; Koch-Brandt C
    J Cell Physiol; 1998 Dec; 177(4):593-605. PubMed ID: 10092212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.